Ying Yuan, Xuefeng Fang, Dan Li, Shanshan Weng, Hanguang Hu, Caixia Dong, Qian Xiao, Da Wang, Xiujun Liao, Jianwei Wang, Lifeng Sun, Dong Xu, Yongmao Song, Jun Li, Sheng Yan, Bo Zhou, Guogang Li, Suzhan Zhang, Ke-Feng Ding. "Tislelizumab combined with standard therapy for conversion treatment in patients with MSS, initially unresectable colorectal cancer liver metastases (CRLM): A prospective, phase II study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.19_suppl.tps159